PT - JOURNAL ARTICLE AU - Neas, Lucas M. AU - Steinhardt, William AU - Hill, K. Lloyd AU - Short, Riley AU - Hubal, Elaine AU - Reich, Brian J AU - Yang, Shu AU - Sheng, Alvin AU - Rappold, Ana G. TI - Fluorosurfactants in groundwater increase the incidence of chronic health conditions among California Medicare beneficiaries AID - 10.1101/2024.02.25.24303330 DP - 2024 Jan 01 TA - medRxiv PG - 2024.02.25.24303330 4099 - http://medrxiv.org/content/early/2024/02/27/2024.02.25.24303330.short 4100 - http://medrxiv.org/content/early/2024/02/27/2024.02.25.24303330.full AB - Background Per- and polyfluoroalkyl substances (PFAS) are persistent organic pollutants with emerging environmental and regulatory concerns.Objectives This study aimed to estimate the burden of PFAS exposures through ground water on the incidence of chronic health conditions among Medicare beneficiaries aged 65 years and older.Methods We estimated PFAS groundwater concentrations for every ZIP code tabulated area (ZCTA) in California counties where 25 percent or more of the population’s drinking water was derived from groundwater. We calculated the annual incidence of non-cancer chronic health conditions among 1,696,247 Medicare beneficiaries aged 65 and older by residential ZCTA over the seven-year study period (2011-2017). A Poisson regression model was used to estimate associations between PFAS groundwater concentration and chronic condition incidence with an offset for the number of beneficiary-years at risk and adjusting for bias due to non-random sampling of wells, use of groundwater for drinking water, demographic characteristics, and lung cancer incidence as a control for smoking.Results Results suggest an association between a 10 ng/L increment in PFAS contaminated groundwater and chronic health conditions including hypertension (+1.15%, 95% confidence interval (CI) 1.01, 1.30), chronic kidney disease (+0.83%, 95% CI 0.68, 0.99) and cataracts (+1.50%, 95% CI 1.35, 1.66).Discussion This small increment in the incidence rate would produce an additional 1,700 new cases of hypertension each year in the study population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was conducted with intramural EPA funds.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UNC Institutional Review BoardI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll exposure data and analytical code will be posted after the manuscript is accepted. Health data is considered sensitive and cannot be posted publicly.ZIP-codeZone Improvement Plan CodeZCTAZip Code Tabulation AreaEPAEnvironmental Protection AgencyGAMAGroundwater Ambient Monitoring and AssessmentACS-5American Community SurveyCESCalEnviroScreenECHOEnforcement and Compliance History OnlineNLCDNational Land Cover DatasetPOLARISProbabilistic Remapping of Soil Survey Geographic DatabasePWSIDPublic Water System Information DatasetCOPDChronic Obstructive Pulmonary DiseaseGWGroundwaterPSPropensity ScoreglmGeneralized Linear ModelXGBoostExtreme Gradient BoostingIQRInner quartile rangeng/Lnanograms per literkmkilometermmeterpHPotential of HydrogenDAGDirected Acyclic GraphPFASPer- and polyfluoroalkyl sulfonic acidsPFOAperfluorooctnoic acidPFOSperfluoroocane sulfonic acidPFHXSAperfluorooctanoic sulfonatePFHAperfluorohexanoic acidPFBSAperfluorobutanesulfonicPFBTAPerfluorobutanoic acidPFPESPerfluoropentanesulfonoic acidPFUNDCAPerfluoroundecanoic acidNMEFOSAAN-Methyl perfluorooctane sulfonamidoacetic acid